Dr. Cima is a cofounder and consultant to the TARIS management team. He is a Professor of Materials Science and Engineering at the Massachusetts Institute of Technology (MIT) and an investigator at the Koch Institute for Integrative Cancer Research at MIT. Dr. Cima is author or coauthor of over 190 peer-reviewed scientific publications and 45 patents, and is a recognized expert in the field of materials processing. He is actively involved in materials and engineered systems aimed at improving human health, such as treatments for cancer, metabolic diseases, trauma and urological disorders. Dr. Cima and collaborators are developing implantable devices for unprecedented control in the delivery of pharmaceuticals. He is also cofounder and a Director of MicroChips Inc., and T2 Biosystems. Most recently, Dr. Cima cofounded Entra Pharmaceuticals and TARIS. Professor Cima earned a B.S. in Chemistry (Phi Beta Kappa) and a Ph.D. in Chemical Engineering, both from the University of California at Berkeley. He joined the MIT faculty in 1986 and was promoted to full Professor in 1995.